Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Tumor Boards
Colleague Insights
Living Resources
Conferences
Nursing Perspectives
Video Expert Opinion
Sign in
Join now

In an effort to better serve our users, we have streamlined our content offering. As a result, we no longer publish new content or update existing content in Renal Cell Carcinoma. Visit the 'Content & Subscriptions' tab of your Settings page at any time to update your Dashboard or Newsletter Subscription preferences to continue to see news and information that interests you most.

featured
Published in Renal Cell Carcinoma

Expert Opinion / Interview · November 03, 2016

Current Perspectives on Rx Sequencing for RCC: 3. Is There Still a Role for IL-2?

Bradley Somer MD
Sumanta Pal MD

 

 Save  Recommend
 Share

Additional Info

  1. Sherman S, Amzal B, Calvo E, et al. An Indirect Comparison of Everolimus Versus Axitinib in US Patients With Advanced Renal Cell Carcinoma in Whom Prior Sunitinib Therapy Failed. Clin Ther. 2015; 37(11):2552–2559.
  2. Pal SK, Signorovitch JE, Reichmann WM, et al. Real-World Effectiveness of Everolimus Subsequent to Different First Targeted Therapies for the Treatment of Metastatic Renal Cell Carcinoma: Synthesis of Retrospective Chart Reviews [published online November 18, 2015]. Clin Genitourin Cancer. DOI: http://dx.doi.org/10.1016/j.clgc.2015.11.011.

Disclosure statements are available on the authors' profiles:

Sumanta Pal MD

Bradley Somer MD

Further Reading

Recently Updated